Remus Pharmaceuticals Limited has informed the Exchange regarding Compliance Certificate pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Structural Digital Database

​ 

Socials:

Leave a Reply

Your email address will not be published. Required fields are marked *